Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00381680 · OUTCOME

Event Free Survival. EFS

Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia · Source last updated 2024-03-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants EFS at 3 yrs3
Interval / dispersion
95% Confidence Interval
Time frame
3 years after enrollment

What was measured

Percentage of patients who were event free at 3 years among those on Standard VCR dosing who did not undergo Hematopoietic Stem Cell Transplant (SCT).

Analysis population: The analysis is limited to eligible patients on regimen A (Standard VCR dosing) who did not undergo SCT.

Groups in this outcome

Regimen A: Standard Vincristine Dosing

Standard VCR dosing (1.5 mg/m\^2, max 2 mg)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Regimen A: Standard Vincristine Dosing142

Reported measurements

Source class 1
Values in percentage of participants EFS at 3 yrs3 · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Regimen A: Standard Vincristine Dosing66.0Not reported58.074.0Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        58.0
        upper Limit
        74.0
        value
        66.0
denoms
  1. counts
    1. group Id
      OG000
      value
      142
    units
    Participants
description
Percentage of patients who were event free at 3 years among those on Standard VCR dosing who did not undergo Hematopoietic Stem Cell Transplant (SCT).
dispersion Type
95% Confidence Interval
groups
  1. description
    Standard VCR dosing (1.5 mg/m\^2, max 2 mg)
    id
    OG000
    title
    Regimen A: Standard Vincristine Dosing
param Type
NUMBER
population Description
The analysis is limited to eligible patients on regimen A (Standard VCR dosing) who did not undergo SCT.
reporting Status
POSTED
time Frame
3 years after enrollment
title
Event Free Survival. EFS
type
PRIMARY
unit Of Measure
percentage of participants EFS at 3 yrs3

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice